Indonesia pharmacy retail sector is in the mid to late growth stage with the presence of over 35,000 drugstores and pharmacies. Both private as well as public pharmacy retail companies have entered the market over the past five years to tap the potential in this sector. For more information on the research report, click https://www.kenresearch.com/healthcare/pharmaceuticals/indonesia-pharmacy-retail-market/143544-91.html

1. Indonesia Pharmacy Retail Market is Driven by Growing
Demand for Generic Drugs and Expansion of Organized
Pharmacy Retail Chains: Ken Research

2. Implementation of JKN (National Health Insurance System) by the government,
growing foreign investment in pharmacy retail sector, expansion of product
portfolio by major pharmacy retail chains were the key factors driving growth in
Indonesia pharmacy retail Market.
Indonesia healthcare market has shown a positive incline during 2012-2017 but
with respect to the expanding population of Indonesia, the market is still
underserved especially in the underdeveloped and rural areas as of 2017. The
report titled “Indonesia Pharmacy Retail Market Outlook to 2022 - By Pharmacies
& Drugstores and By Region (Central Java, East Java, West Java, North Sumatra,
Jakarta and Others)” by Ken Research suggested a growth at a CAGR of 8.9% in
revenue in Indonesia pharmacy retail Market by 2022
Indonesia pharmacy retail sector is in the mid to late growth stage with the
presence of over 35,000 drugstores and pharmacies. Both private as well as public
pharmacy retail companies have entered the market over the past five years to tap
the potential in this sector. Furthermore, already established players such
Guardian Pharmacy, Kimia Farma, Apotek K-24 have increased their number of
pharmacy retail outlets over the period 2012-2017.

3. The number of pharmacies operated by Guardian pharmacy reached over 300 in
2016 whereas for Kimia Farma, the number of pharmacies increased from over
500 in 2013 to over 800 stores in 2016. Over 2012-2017, the number of pharmacies
& drugstores has inclined at a positive CAGR. Major organized chains have
invested in expanding their capabilities by focusing on value added services such
as home delivery, prescription records, and medicine consumption reminder
services in order to become a one stop solution for all pharmacy needs of the
customer.
The implementation JKN scheme has led to an increased demand for generic
drugs as the government has mandated the use of generic medicines due to lower
cost of drugs.
The market is expected to witness an increase in demand for nutritional products
and dietary supplements due to sedentary lifestyle and expansion of online retail
sales channel to increase accessibility in the market.
For more information on the research report, refer to below link:-
https://www.kenresearch.com/healthcare/pharmaceuticals/indonesia-pharmacy-
retail-market/143544-91.html

4. Related Reports by Ken Research:
https://www.kenresearch.com/healthcare/general-healthcare/saudi-arabia-
healthcare-market-research-report/1106-91.html
https://www.kenresearch.com/healthcare/general-healthcare/uae-healthcare-
market-report/37505-91.html
https://www.kenresearch.com/healthcare/general-healthcare/qatar-healthcare-
market-report/99730-91.html
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Sales@kenresearch.com
+91-9015378249